Wed, March 7, 2012
Tue, March 6, 2012
[ Tue, Mar 06th 2012 ] - Market Wire
Verotoxin and E. coli 0157
Mon, March 5, 2012
[ Mon, Mar 05th 2012 ] - Market Wire
Sienna Gold Warrants Extended
[ Mon, Mar 05th 2012 ] - Market Wire
30 a.m. ET
Fri, March 2, 2012
Thu, March 1, 2012
Wed, February 29, 2012
Tue, February 28, 2012
[ Tue, Feb 28th 2012 ] - Market Wire
Alere to Acquire eScreen, Inc.
[ Tue, Feb 28th 2012 ] - Market Wire
ICON Acquires PriceSpective
Mon, February 27, 2012
Sat, February 25, 2012
Fri, February 24, 2012
[ Fri, Feb 24th 2012 ] - Market Wire
BrainStorm Featured on CNBC
Thu, February 23, 2012

Amgen to Present at the Cowen and Company 32nd Annual Healthcare Conference


//health-fitness.news-articles.net/content/2012/ .. d-company-32nd-annual-healthcare-conference.html
Published in Health and Fitness on Wednesday, February 29th 2012 at 13:23 GMT by Market Wire   Print publication without navigation


Amgen to Present at the Cowen and Company 32nd Annual Healthcare... -- THOUSAND OAKS, Calif., Feb. 29, 2012 /PRNewswire/ --

Amgen to Present at the Cowen and Company 32nd Annual Healthcare Conference

[ ]

THOUSAND OAKS, Calif., Feb. 29, 2012 /PRNewswire/ -- Amgen (NASDAQ: [ AMGN ]) will present at the Cowen and Company 32ndAnnual Healthcare Conference on Monday, March 5, 2012 at the Boston Marriott Copley Place, Boston, Mass., beginning at approximately 2:50 p.m. Eastern Standard TimeJonathan M. Peacock, executive vice president and chief financial officer at Amgen, will present. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, [ www.amgen.com ], under Investors.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit [ www.amgen.com ]. Follow us on [ www.twitter.com/amgen ].

CONTACT: Amgen, Thousand Oaks
Christine Regan, 805-447-5476 (media)
Arvind Sood, 805-447-1060 (investors)

(Logo:  [ http://photos.prnewswire.com/prnh/20081015/AMGENLOGO ])

 

SOURCE Amgen

[ Back to top ]

RELATED LINKS
[ http://www.amgen.com ]


Publication Contributing Sources